Bio-Manguinhos and new generation of vaccines: consolidation of mRNA-LNP production and evaluation of critical quality attributes at pilot scale

Key Points

• The aim is to evaluate the production and critical quality attributes of mRNA-based vaccines at a pilot scale.
• Pilot-scale production of mRNA-lipid nanoparticle (LNP) vaccines
• Assessment of critical quality attributes during production
• Participation in the International Symposium on Immunobiologicals
• Successful consolidation of mRNA-LNP production processes
• Improvement in the evaluation of vaccine quality attributes
• Presentation aligns with current advancements in vaccine technology